Here is the synopsis of our sample research paper on Cheap Drugs for Africa; The Moral Issues of Treating AIDS. Have the paper e-mailed to you 24/7/365.
Essay / Research Paper Abstract
This 10 page paper considers the ethical and legal issues that are relevant when considering the need of developing nations to access essential drugs, such as those for HIV/AIDS. Issues such are moral responsibility, profit, investment, protection and patents are also considered. Patent law referent to is both international and UK is approach. The bibliography cites 10 sources.
Page Count:
10 pages (~225 words per page)
File: TS14_TEdrugai.rtf
Buy This Term Paper »
 
Unformatted sample text from the term paper:
need for long-term research, much of which may not end in a tangible commercial product. The drugs companies may produces goods that can save many lives or improve the quality
of those lives, however, this does not detract from the fact they are commercial enterprises with shareholders as the major stakeholder, who expect a return on their investment. When issues
of ethic are considered such as the plight of the thousands of people in Africa with AIDs; a country which cannot afford the drugs to treat the sufferers. Here there
is a scenario where there are treatments available, but are not being used. The issue is cost, if drugs companies believe they will make be left in a position where
they are not making a profit, and possibility making a loss, despite the moral high ground, they are unlikely to undertake research into similar areas in the future, as it
is uneconomic. If they are placed in a difficult position, with negative publicity; portrayed as the uncaring capitalists corporate giant the only way they can ensure they are not
exposed to a similar position in the future is the avoid undertaking research in areas where this conflict ay occur. This may result in drugs no being developed.
Conversely, where the drugs are required, and profits are being made in the developed world, it may be argued that there is a responsibility
to share the drugs or the knowledge. That money should not be the issue when it comes to a potential 40 million victims that are currently suffering from the HIV
virus, the majority of which are in Africa (Krauss, 2003). This is an addition the 3 million that have already died (Krauss, 2003). In this argument drugs should be supplied
...